HIV/AIDS and colorectal cancer: A review in the era of antiretrovirals

Gastroenterology and Hepatology

Volumn 4, Issue 4, 2008, Pages 274-278

  Ford, Ryan M ^a,b   McMahon, Matthew M ^a   Wehbi, Mohammad A ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

Colorectal cancer; HIV AIDS

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CANCER RISK; CAUSE OF DEATH; CD4 LYMPHOCYTE COUNT; COLON CANCER; COLORECTAL CANCER; DISEASE ASSOCIATION; DISEASE DURATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ONSET AGE; OPPORTUNISTIC INFECTION;

EID: 43249092807     PISSN: 15547914     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Klugman AD, Schaffner J. Colon adenocarcinoma in HIV infection: a case report and review. Am J Gastroenterol. 1994;89:254-256.
2. Monfardini S, Vaccher E, Pizzocaro G, Stellini R, Sinicco A, et al. Unusual malignant tumors in 49 patients with HIV infection. AIDS. 1989;3:449-452.
3. Cappell MS, Yao F, Cho KC. Colonic adenocarcinoma associated with the acquired immune deficiency syndrome. Cancer. 1988;62:616-619.
4. Ravalli S, Chabon AB, Khan AA. Gastrointestinal neoplasia in young HIV antibody-positive patients. Am J Clin Pathol. 1989;91:458-461.
5. Burnet FM. The concept of immunological surveillance. Prog Exp Tumor Res. 1970;13:1-27.
6. Grulich AE, van Leeuwen MT, Falster MO, Vajdic CM. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet. 2007;370:59-67.
7. Serraino D, Piselli P, Busnach G, Burra P, Citterio F, et al. Risk of cancer following immunosuppression in organ transplant recipients and in HIV-positive individuals in southern Europe. Eur J Cancer. 2007;43:2117-2123.
8. Palella FJ Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med. 1998;338:853-860.
9. Palella FJ Jr, Baker RK, Moorman AC, Chmiel JS, Wood KC, et al. Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study. J Acquir Immune Defic Syndr. 2006;43:27-34.
10. Messeri P, Lee G, Abramson DM, Aidala A, Chiasson MA, Jessop DJ. Antiretroviral therapy and declining AIDS mortality in New York City. Med Care. 2003;41:512-521.
11. Wood E, Low-Beer S, Bartholomew K, Landolt M, Oram D, et al. Modern antiretroviral therapy improves life expectancy of gay and bisexual males in Vancouver's West End. Can J Public Health. 2000;91:125-128.
12. Lai D, Hardy RJ. An update on the impact of HIV/AIDS on life expectancy in the United States. AIDS. 2004;18:1732-1734.
13. Louie JK, Hsu LC, Osmond DH, Katz MH, Schwarcz SK. Trends in causes of death among persons with acquired immunodeficiency syndrome in the era of highly active antiretroviral therapy, San Francisco, 1994-1998. J Infect Dis. 2002;186:1023-1027.
14. Mocroft A, Ledergerber B, Katlama C, Kirk O, Reiss P, et al. Decline in the AIDS and death rates in the EuroSIDA study: an observational study. Lancet. 2003;362:22-29.
15. Mocroft A, Gatell J, Reiss P, Ledergerber B, Kirk O, et al. Causes of death in HIV infection: the key determinant to define the clinical response to anti-HIV therapy. AIDS. 2004;18:2333-2337.
16. Smith DK, Gardner LI, Phelps R, Hamburger ME, Carpenter C, et al. Mortality rates and causes of death in a cohort of HIV-infected and uninfected women, 1993-1999. J Urban Health. 2003;80:676-688.
17. Aberg JA, Gallant JE, Anderson J, Oleske JM, Libman H, et al. Primary care guidelines for the management of persons infected with human immunodeficiency virus: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis. 2004;39:609-629.
18. Aberg JA. The changing face of HIV care: common things really are common. Ann Intern Med. 2006;145:463-465.
19. Porter K, Babiker A, Bhaskaran K, Darbyshire J, Pezzotti P, et al. Determinants of survival following HIV-1 seroconversion after the introduction of HAART. Lancet. 2003;362:1267-1274.
20. Murphy EL, Collier AC, Kalish LA, Assmann SF, Para MF, et al. Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV disease. Ann Intern Med. 2001;135:17-26.
21. Newnham A, Harris J, Evans HS, Evans BG, Møller H. The risk of cancer in HIV-infected people in southeast England: a cohort study. Br J Cancer. 2005;92:194-200.
22. Bini EJ, Park J, Francois F. Use of flexible sigmoidoscopy to screen for colorectal cancer in HIV-infected patients 50 years of age and older. Arch Intern Med. 2006;166:1626-1632.
23. Burgi A, Brodine S, Wegner S, Milazzo M, Wallace MR, et al. Incidence and risk factors for the occurrence of non-AIDS-defining cancers among human immunodeficiency virus-infected individuals. Cancer. 2005;104:1505-1511.
24. Lewden C, Salmon D, Morlat P, Bévilacqua S, Jougla E, et al. Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of AIDS. Int J Epidemiol. 2005;34:121-130.
25. Bonnet F, Lewden C, May T, Heripret L, Jougla E, et al. Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy. Cancer. 2004;101:317-324.
26. Herida M, Mary-Krause M, Kaphan R, Cadranel J, Poizot-Martin I, et al. Incidence of non-AIDS-defining cancers before and during the highly active antiretroviral therapy era in a cohort of human immunodeficiency virus-infected patients. J Clin Oncol. 2003;21:3447-3453.
27. Dhir AA, Sawant S, Dikshit RP, Parikh P, Srivastava S, et al. Spectrum of HIV/AIDS related cancers in India. Cancer Causes Control. 2008;19:147-153.
28. Cinti SK, Gandhi T, Riddell J 4th. Non-AIDS-defining cancers: should antiretroviral therapy be initiated earlier? AIDS Read. 2008;18:18-20, 26-32.
29. Long JL, Engels EA, Moore RD, Gebo KA. Incidence and outcomes of malignancy in the HAART era in an urban cohort of HIV-infected individuals. AIDS. 2008;22:489-496.
30. Silverberg MJ, Abrams DI. AIDS-defining and non-AIDS-defining malignancies: cancer occurrence in the antiretroviral therapy era. Curr Opin Oncol. 2007;19:446-451.
31. Cooley TP. Non-AIDS-defining cancer in HIV-infected people. Hematol Oncol Clin North Am. 2003;17:889-899.
32. Manfredi R. HIV disease and advanced age: an increasing therapeutic challenge. Drugs Aging. 2002;19:647-669.
33. Pignone M, Rich M, Teutsch SM, Berg AO, Lohr KN. Screening for colorectal cancer in adults at average risk: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2002;137:132-141.
34. Rex DK, Johnson DA, Lieberman DA, Burt RW, Sonnenberg A. Colorectal cancer prevention 2000: Screening recommendations of the American College of Gastroenterology. Am J Gastroenterol. 2000;95:868-877.
35. Winawer S, Fletcher R, Rex D, Bond J, Burt R, et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale-update based on new evidence. Gastroenterology. 2003;124:544-560.
36. Goedert JJ, Cote TR, Virgo P, Scoppa SM, Kingma DW, et al. Spectrum of AIDS-associated malignant disorders. Lancet. 1998;351:1833-1839.
37. Selik RM, Rabkin CS. Cancer death rates associated with human immunodeficiency virus infection in the United States. J Natl Cancer Inst. 1998;90:1300-1302.
38. Grulich AE, Wan X, Law MG, Coates M, Kaldor JM. Risk of cancer in people with AIDS. AIDS. 1999;13:839-843.
39. Cooksley CD, Hwang LY, Waller DK, Ford CE. HIV-related malignancies: community-based study using linkage of cancer registry and HIV registry data. Int J STD AIDS. 1999;10:795-802.
40. Gallagher B, Wang Z, Schymura MJ, Kahn A, Fordyce EJ. Cancer incidence in New York State acquired immunodeficiency syndrome patients. Am J Epidemiol. 2001;154:544-556.
41. Frisch M, Biggar RJ, Engels EA, Goedert JJ; AIDS-Cancer Match Registry Study Group. Association of cancer with AIDS-related immunosuppression in adults. JAMA. 2001;285:1736-1745.
42. Yeguez JF, Martinez SA, Sands DR, Sands LR, Hellinger MD. Colorectal malignancies in HIV-positive patients. Am Surg. 2003;69:981-987.
43. Demopoulos BP, Vamvakas E, Ehrlich JE, Demopoulos R. Non-acquired immunodeficiency syndrome-defining malignancies in patients infected with human immunodeficiency virus. Arch Pathol Lab Med. 2003;127:589-592.
44. Bedimo R, Chen RY, Accortt NA, Raper JL, Linn C, et al. Trends in AIDS-defining and non-AIDS-defining malignancies among HIV-infected patients: 1989-2002. Clin Infect Dis. 2004;39:1380-1384.
45. Clifford GM, Polesel J, Rickenbach M, Dal Maso L, Keiser O, et al. Cancer risk in the Swiss HIV cohort study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J Natl Cancer Inst. 2005;97:425-432.
46. Engels EA, Pfeiffer RM, Goedert JJ, Virgo P, McNeel TS, et al. Trends in cancer risk among people with AIDS in the United States 1980-2002. AIDS. 2006;20:1645-1654.
47. Sackoff JE, Hanna DB, Pfeiffer MR, Torian LV. Causes of death among persons with AIDS in the era of highly active antiretroviral therapy: New York City. Ann Intern Med. 2006;145:397-406.
48. Reinhold JP, Moon M, Tenner CT, Poles MA, Bini EJ. Colorectal cancer screening in HIV-infected patients 50 years of age and older: missed opportunities for prevention. Am J Gastroenterol. 2005;100:1805-1812.
49. Berretta M, Tirelli U. Colorectal cancer screening in HIV-infected patients 50 years of age and older: missed opportunities for prevention. Am J Gastroenterol. 2006;101:907.
50. Wasserberg N, Nunoo-Mensah JW, Gonzalez-Ruiz C, Beart RW Jr, Kaiser AM. Colorectal cancer in HIV-infected patients: a case control study. Int J Colorectal Dis. 2007;22:1217-1221.
51. Mbulaiteye SM, Biggar RJ, Goedert JJ, Engels EA. Immune deficiency and risk for malignancy among persons with AIDS. J Acquir Immune Defic Syndr. 2003;32:527-533.
52. Meng Q, Walker DM, Olivero OA, Shi X, Antiochos BB, et al. Zidovudine-didanosine coexposure potentiates DNA incorporation of zidovudine and mutagenesis in human cells. Proc Natl Acad Sci U S A. 2000;97:12667-32671.
53. Lim ST, Levine AM. Non-AIDS-defining cancers and HIV infection. Curr HIV/AIDS Rep. 2005;2:146-153.
54. Pantanowitz L, Schlecht HP, Dezube BJ. The growing problem of non-AIDS-defining malignancies in HIV. Curr Opin Oncol. 2006;18:469-478.